Comparing 2 hypotheses side-by-side
The NAD+ salvage pathway represents the primary mechanism for maintaining cellular NAD+ homeostasis in neurons, with NAMPT (nicotinamide phosphoribosyltransferase) serving as the rate-limiting enzyme that converts nicotinamide to nicotinamide mononucleotide (NMN). During neurodegeneration, NAMPT expression progressively declines due to inflammatory cytokine-mediated transcriptional suppression and age-related epigenetic silencing of the NAMPT promoter. This creates a fundamental metabolic crisis
The TREM2 R47H variant has been associated with disrupted metabolic reprogramming relevant to microglial transition from homeostatic to disease-associated states. Studies using single-nucleus transcriptomics have revealed both TREM2-dependent and TREM2-independent microglial responses in Alzheimer's disease, supporting a role for TREM2 in disease-associated microglia (DAM) commitment (pmid:31932797). Evidence indicates that metabolic dysfunction with impaired glycolytic metabolism contributes to
| Dimension | Metabolic NAD+ Salvage Pathway | TREM2 R47H Variant-Driven Meta |
|---|---|---|
| Mechanistic | 0.900 | 0.550 |
| Evidence | 0.780 | 0.600 |
| Novelty | 0.680 | 0.650 |
| Feasibility | 0.840 | 0.500 |
| Impact | 0.770 | 0.750 |
| Druggability | 0.900 | 0.600 |
| Safety | 0.800 | 0.550 |
| Competition | 0.750 | 0.550 |
| Data | 0.900 | 0.700 |
| Reproducible | 0.850 | 0.600 |
No evidence citations yet
No evidence citations yet
4 rounds · quality: 0.95
Based on the provided literature on epigenetic reprogramming in aging neurons, I'll generate novel therapeutic hypotheses that bridge current knowledge gaps: ## Hypothesis 1: Temporal Chromatin Oscil...
I'll provide a rigorous critique of each hypothesis, identifying weaknesses, counter-evidence, and proposing falsification experiments. ## Hypothesis 1: Temporal Chromatin Oscillator Reset Therapy **...
# Practical Feasibility Assessment of Epigenetic Reprogramming Hypotheses Based on the critique provided, I'll focus on the most viable hypotheses and assess their practical druggability, competitive...
```json { "ranked_hypotheses": [ { "title": "Glial-Neuronal Epigenetic Cross-Talk Restoration", "description": "Aging disrupts epigenetic communication between astrocytes and neurons...
4 rounds · quality: 1.00
# Mechanistically-Specific Hypotheses: Microglial State Transitions in Alzheimer's Disease --- ## Hypothesis 1: TREM2→TYROBP→APOE Epigenetic Checkpoint as Molecular Gate for Irreversible Transitio...
# Skeptic's Critical Evaluation: Microglial State Transition Hypotheses --- ## Hypothesis 1: TREM2→TYROBP→APOE Epigenetic Checkpoint ### Strongest Specific Weakness **The mechanistic directional...
# Domain Expert Assessment: Microglial State Transition Hypotheses ## 1. Hypotheses with Highest Translational Potential ### Hypothesis A: TREM2 Agonism to Sustain Protective Microglial Responses ...
{ "ranked_hypotheses": [ { "rank": 1, "title": "TREM2 Agonism to Sustain Protective Microglial Responses", "mechanism": "TREM2 agonistic antibodies enhance microglial phagocy...
Curated mechanism pathway diagrams from expert analysis
graph TD
A["Dietary Nutrients<br/>(NAD+ precursors: NR, NMN, tryptophan)"] --> B["NAMPT<br/>(rate-limiting NAD+ biosynthesis)"]
B --> C["NAD+ Pool<br/>(neuronal ~400-500 muM)"]
C --> D["SIRT1 Activation<br/>(NAD+-dependent deacetylase)"]
subgraph "SIRT1 Deacetylation Targets"
D --> E["PGC1alpha Deacetylation<br/>(K13, K779)"]
D --> F["FOXO3a Deacetylation<br/>(stress resistance genes)"]
D --> G["p53 Deacetylation<br/>(K382 - reduced apoptosis)"]
D --> H["NF-kappaB p65 Deacetylation<br/>(anti-inflammatory)"]
end
subgraph "AMPK Pathway"
I["AMPK Activation<br/>(energy sensor)"] --> J["PGC1alpha Phosphorylation<br/>(T177, S538)"]
I --> K["ACC Phosphorylation<br/>(inhibits malonyl-CoA)"]
K --> L["CPT1 Disinhibition<br/>(fatty acid oxidation)"]
L --> M["Increased NAD+/NADH<br/>(feedback to SIRT1)"]
end
E --> N["Mitochondrial Biogenesis<br/>(NRF1, NRF2, TFAM)"]
J --> N
N --> O["Enhanced Mitochondrial<br/>Function and Neuronal Health"]
F --> O
G --> O
H --> O
M --> D
P["Therapeutic Intervention<br/>(SIRT1 Activators/NAD+ Boosters)"] --> D
subgraph "Aging-Related Decline"
Q["Epigenetic Silencing"] --> R["Reduced SIRT1 Activity"]
S["Decreased NAD+ Levels"] --> R
T["Impaired Autophagy"] --> R
end
R -.-> U["Neurodegeneration<br/>(metabolic dysfunction)"]
P -.-> V["Circuit Reactivation<br/>(reversal of aging)"]